T-cell Immunotherapy and Cardiovascular Disease: Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies

By rosaguerrero • June 20, 2022

Stein-Merlob AF, Ganatra S, Yang EH. T-cell Immunotherapy and Cardiovascular Disease: Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies. Heart Fail Clin. 2022 Jul;18(3):443-454. doi: 10.1016/j.hfc.2022.02.008. PMID: 35718418.

Tags: Bispecific T-cell engager (BiTE) therapy, cardio-oncology, Cardiology/Epi, cardiotoxicity, Chimeric Antigen Receptor (CAR) T-cell therapy, immunotherapy, Publications

T cell immune senescence is associated with frailty and sarcopenia in lung transplant candidates

Schaenman JM, Pickering H, Reed EF, Rossetti M, Seligman B, Weigt SS, Shino M, Sayah D, Belperio J, Hu A, Prosper A, Ruchalski K, Ardehali[...]

Barriers and solutions in women’s health research and clinical care: a call to action

Regensteiner JG, McNeil M, Faubion SS, Bairey-Merz CN, Gulati M, Joffe H, Redberg RF, Rosen SE, Reusch JE, Klein W. Barriers and solutions in women's[...]

In-person versus virtual heart transplantation selection committee meetings: Longer-term impact on committee member perceptions and patient selection outcomes

Chen JY, Shan R, Fraschilla S, Moore M, Hsu JJ, Shahandeh N, Ardehali A, Nsair A, Parikh RV. In-person versus virtual heart transplantation selection committee[...]